Making decisions with real-world evidence and COVID-19
The COVID-19 pandemic has triggered intense and widespread action among the biopharma industry and...
The COVID-19 pandemic has triggered intense and widespread action among the biopharma industry and...
Few areas of medicine have captured public interest over the past two years quite like glucagon-like peptide-1 (GLP-1) receptor agonists. Originally developed to improve glycemic control in type 2 diabetes, drugs like semaglutide (Ozempic/Wegovy) and...